QVIDTVM Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

QVIDTVM Management’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-83,671	Closed	-$1.63M	–	9
2024 Q4	$1.63M	Buy	83,671 +113	+0.1%	+$2.1K	1.31%	8
2024 Q3	$1.31M	Hold	83,558	–	–	0.92%	8
2024 Q2	$706K	Buy	83,558 +1	+0%	+$12	0.56%	7
2024 Q1	$1.29M	Buy	83,557 +6,236	+8%	+$95.1K	1.04%	8
2023 Q4	$1.07M	Buy	77,321 +37,708	+95%	+$446K	0.9%	8
2023 Q3	$453K	Buy	+39,613	New	+$736K	0.35%	11

QVIDTVM Management's OMIC Position: Q1 2025 in Review

QVIDTVM Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2025, closing a stake of 83,671 shares — an estimated $1.63M sold.

QVIDTVM Management first reported a position in OMIC in Q3 2023 and held it in 6 quarters. The position peaked at $1.63M in Q4 2024. 0 funds tracked by Wall St. Rank hold OMIC as of Q1 2025.

QVIDTVM Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
QVIDTVM Management sold 83,671 Singular Genomics Systems, Inc. Common Stock shares in Q1 2025, an estimated $1.63M.
QVIDTVM Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2023 and held it in 6 quarters.
QVIDTVM Management's Singular Genomics Systems, Inc. Common Stock position peaked at $1.63M in Q4 2024.
0 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2025.

Based on QVIDTVM Management's 13F filing for Q1 2025, filed 12 May 2025.